These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
276 related items for PubMed ID: 27446823
1. Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada. Burak KW, Meeberg GA, Myers RP, Fick GH, Swain MG, Bain VG, Kneteman NM, Hilsden RJ. Can J Gastroenterol Hepatol; 2016; 2016():1329532. PubMed ID: 27446823 [Abstract] [Full Text] [Related]
2. Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant. Bazarah SM, Peltekian KM, McAlister VC, Bitter-Suermann H, MacDonald AS. Clin Invest Med; 2004 Aug; 27(4):162-7. PubMed ID: 15453152 [Abstract] [Full Text] [Related]
4. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list. Myers RP, Tandon P, Ney M, Meeberg G, Faris P, Shaheen AA, Aspinall AI, Burak KW. Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642 [Abstract] [Full Text] [Related]
5. Model for end-stage liver disease (MELD) and allocation of donor livers. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score Committee. Gastroenterology; 2003 Jan; 124(1):91-6. PubMed ID: 12512033 [Abstract] [Full Text] [Related]
6. Could metabolic liver function tests predict mortality on waiting list for liver transplantation? A study on 560 patients. Ecochard M, Boillot O, Guillaud O, Roman S, Adham M, Mion F, Dumortier J. Clin Transplant; 2011 Jan; 25(5):755-65. PubMed ID: 21158918 [Abstract] [Full Text] [Related]
7. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality. Starlinger P, Ahn JC, Mullan A, Gyoeri GP, Pereyra D, Alva-Ruiz R, Hackl H, Reiberger T, Trauner M, Santol J, Simbrunner B, Mandorfer M, Berlakovich G, Kamath PS, Heimbach J. Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862 [Abstract] [Full Text] [Related]
8. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality. Abdallah MA, Kuo YF, Asrani S, Wong RJ, Ahmed A, Kwo P, Terrault N, Kamath PS, Jalan R, Singal AK. J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814 [Abstract] [Full Text] [Related]
9. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P. BMC Gastroenterol; 2009 Sep 25; 9():72. PubMed ID: 19778459 [Abstract] [Full Text] [Related]
10. End-stage liver disease patients with MELD >40 have higher waitlist mortality compared to Status 1A patients. Ahn J, Bhuket T, Mosadeghi S, Frenette C, Liu B, Wong RJ. Hepatol Int; 2016 Sep 25; 10(5):838-46. PubMed ID: 27221700 [Abstract] [Full Text] [Related]
13. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group. J Hepatol; 2014 Feb 25; 60(2):290-7. PubMed ID: 24161408 [Abstract] [Full Text] [Related]
14. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. Biselli M, Dall'Agata M, Gramenzi A, Gitto S, Liberati C, Brodosi L, Ravaioli M, Gambato M, Montalti R, Pinna AD, Burra P, Gerunda GE, Cillo U, Andreone P, Bernardi M. Liver Int; 2015 Jan 25; 35(1):184-91. PubMed ID: 24650058 [Abstract] [Full Text] [Related]
15. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil. Marroni CP, de Mello Brandão AB, Hennigen AW, Marroni C, Zanotelli ML, Cantisani G, Fuchs SC, Liver Transplantation Group. Clin Transplant; 2012 Jan 25; 26(4):E395-401. PubMed ID: 22882694 [Abstract] [Full Text] [Related]
16. Impact of the MELD allocation after its implementation in liver transplantation. Benckert C, Quante M, Thelen A, Bartels M, Laudi S, Berg T, Kaisers U, Jonas S. Scand J Gastroenterol; 2011 Jul 25; 46(7-8):941-8. PubMed ID: 21443420 [Abstract] [Full Text] [Related]
17. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality. Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Aoki T, Sakamoto Y, Hasegawa K, Koike K, Kokudo N. Transplant Proc; 2012 Mar 25; 44(2):389-92. PubMed ID: 22410024 [Abstract] [Full Text] [Related]
18. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A. Dig Dis Sci; 2018 Jun 25; 63(6):1647-1653. PubMed ID: 29611079 [Abstract] [Full Text] [Related]
19. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease. Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS. J Hepatol; 2017 Sep 25; 67(3):517-525. PubMed ID: 28483678 [Abstract] [Full Text] [Related]
20. Sex Disparity in Liver Transplant and Access to Living Donation. Karnam RS, Chen S, Xu W, Chen C, Elangainesan P, Ghanekar A, McGilvray I, Reichman T, Sayed B, Selzner M, Sapisochin G, Galvin Z, Hirschfield G, Asrani SK, Selzner N, Cattral M, Lilly L, Bhat M. JAMA Surg; 2021 Nov 01; 156(11):1010-1017. PubMed ID: 34406347 [Abstract] [Full Text] [Related] Page: [Next] [New Search]